Aster DM Healthcare Limited

INR 11,933

C : 264 (240) India : 2573 (131) India : 205 (114) Largest Number of Medical Centers/Polyclinics INR 11,933 Cr (10,253 Cr) Revenue6 GCC : INR 8,950 Cr (INR 7,870 Cr) India : INR 2,983 Cr (INR 2,384 Cr) 885

INR 8,950

205 (114) Largest Number of Medical Centers/Polyclinics INR 11,933 Cr (10,253 Cr) Revenue6 GCC : INR 8,950 Cr (INR 7,870 Cr) India : INR 2,983 Cr (INR 2,384 Cr) 885 (632) Total Facilities Net Unit Addition

INR 7,870

gest Number of Medical Centers/Polyclinics INR 11,933 Cr (10,253 Cr) Revenue6 GCC : INR 8,950 Cr (INR 7,870 Cr) India : INR 2,983 Cr (INR 2,384 Cr) 885 (632) Total Facilities Net Unit Additions in FY23 Q4 T

INR 2,983

Centers/Polyclinics INR 11,933 Cr (10,253 Cr) Revenue6 GCC : INR 8,950 Cr (INR 7,870 Cr) India : INR 2,983 Cr (INR 2,384 Cr) 885 (632) Total Facilities Net Unit Additions in FY23 Q4 Total : 2 Hospitals | 2

INR 2,384

linics INR 11,933 Cr (10,253 Cr) Revenue6 GCC : INR 8,950 Cr (INR 7,870 Cr) India : INR 2,983 Cr (INR 2,384 Cr) 885 (632) Total Facilities Net Unit Additions in FY23 Q4 Total : 2 Hospitals | 25 Pharmacies

rs7

Experience Centers One of the Largest Chain of Pharmacies 30,330* (25,806) Human Resources Doctors7 : 3,863 : 8,975 Nurses Others8 : 13,318 Outsourced8 : 4,174 5,756 (5,065) Capacity Beds 19.9 Mn

rs8

Largest Chain of Pharmacies 30,330* (25,806) Human Resources Doctors7 : 3,863 : 8,975 Nurses Others8 : 13,318 Outsourced8 : 4,174 5,756 (5,065) Capacity Beds 19.9 Mn (18.6 Mn) Patient Visits GCC :

Rs. 3,165

and Profitability Snapshot – FY23 Q4 Revenue from Operations ▪ Revenue excluding new hospitals4 is Rs. 3,165 Crs. (Growth of 16%) EBITDA (excl. Other Income) ▪ EBITDA excluding new hospitals4 is Rs. 532 Crs.

16%

– FY23 Q4 Revenue from Operations ▪ Revenue excluding new hospitals4 is Rs. 3,165 Crs. (Growth of 16%) EBITDA (excl. Other Income) ▪ EBITDA excluding new hospitals4 is Rs. 532 Crs. (Growth of 15%, EBI

Rs. 532

is Rs. 3,165 Crs. (Growth of 16%) EBITDA (excl. Other Income) ▪ EBITDA excluding new hospitals4 is Rs. 532 Crs. (Growth of 15%, EBITDA Margin of 16.8%) ▪ PAT PAT (Post-NCI) (Post-NCI) new excluding is Rs.

15%

h of 16%) EBITDA (excl. Other Income) ▪ EBITDA excluding new hospitals4 is Rs. 532 Crs. (Growth of 15%, EBITDA Margin of 16.8%) ▪ PAT PAT (Post-NCI) (Post-NCI) new excluding is Rs. 235 Crs. (Growth

16.8%

l. Other Income) ▪ EBITDA excluding new hospitals4 is Rs. 532 Crs. (Growth of 15%, EBITDA Margin of 16.8%) ▪ PAT PAT (Post-NCI) (Post-NCI) new excluding is Rs. 235 Crs. (Growth hospitals4 of 1%, PAT Ma

Source

1

Source

1. english.alarabiya.net 2. worldpopulationreview.com 3. 4. omanobserver.com edsfze.com Aster - Awards & Service Excellence 20 Dr. Azad Moopen • • • • • Alisha Moopen • • • • • • 6 JCI Accredited Aster Hospital Mankhool, Qusais and Day Care Surgery Centre in UAE “Saudi Central Board for Accreditation for Healthcare Institutions (CBAHI)” DNV Accreditation – Orthopaedics Centre of Excellence Accreditation from European Society of Medical Oncology NABH and NABL Accreditations JCI Accredited HIMMS Accreditation (Stage 6) Aster Mankhool SRV Accreditation - Endometriosis Aster - Awards UAE Innovation Award Dubai Quality Award DQA - DQAA Times All India Multispecialty Hospitals Ranking Survey 2021 IHF ICC Healthcare Excellence Awards The Economics Times Healthcare Awards World Stroke Association Rating Newsweek World’s Best Hospitals International Best Practices ACE recognition by CAHO for CSSD FICCI Harvard Business Council Awards Outlook's Best Hospital Ranking 2022 LinkedIn Aster Top 5 Dub